BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34590286)

  • 1. Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring.
    de Viron S; Trotta L; Schumacher H; Lomp HJ; Höppner S; Young S; Buyse M
    Ther Innov Regul Sci; 2022 Jan; 56(1):130-136. PubMed ID: 34590286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central statistical monitoring: detecting fraud in clinical trials.
    Pogue JM; Devereaux PJ; Thorlund K; Yusuf S
    Clin Trials; 2013 Apr; 10(2):225-35. PubMed ID: 23283577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring.
    Trotta L; Kabeya Y; Buyse M; Doffagne E; Venet D; Desmet L; Burzykowski T; Tsuburaya A; Yoshida K; Miyashita Y; Morita S; Sakamoto J; Praveen P; Oba K
    Clin Trials; 2019 Oct; 16(5):512-522. PubMed ID: 31331195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computationally simple central monitoring procedure, effectively applied to empirical trial data with known fraud.
    van den Bor RM; Vaessen PWJ; Oosterman BJ; Zuithoff NPA; Grobbee DE; Roes KCB
    J Clin Epidemiol; 2017 Jul; 87():59-69. PubMed ID: 28412468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for dealing with fraud in clinical trials.
    Herson J
    Int J Clin Oncol; 2016 Feb; 21(1):22-7. PubMed ID: 26194810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials.
    Buyse M; George SL; Evans S; Geller NL; Ranstam J; Scherrer B; Lesaffre E; Murray G; Edler L; Hutton J; Colton T; Lachenbruch P; Verma BL
    Stat Med; 1999 Dec; 18(24):3435-51. PubMed ID: 10611617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data fraud in clinical trials.
    George SL; Buyse M
    Clin Investig (Lond); 2015; 5(2):161-173. PubMed ID: 25729561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical challenges for central monitoring in clinical trials: a review.
    Oba K
    Int J Clin Oncol; 2016 Feb; 21(1):28-37. PubMed ID: 26499195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data-driven risk identification in phase III clinical trials using central statistical monitoring.
    Timmermans C; Venet D; Burzykowski T
    Int J Clin Oncol; 2016 Feb; 21(1):38-45. PubMed ID: 26233672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting Data Quality Issues in Clinical Trials: Current Practices and Recommendations.
    Knepper D; Fenske C; Nadolny P; Bedding A; Gribkova E; Polzer J; Neumann J; Wilson B; Benedict J; Lawton A
    Ther Innov Regul Sci; 2016 Jan; 50(1):15-21. PubMed ID: 30236017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical Monitoring in Clinical Trials: Best Practices for Detecting Data Anomalies Suggestive of Fabrication or Misconduct.
    Knepper D; Lindblad AS; Sharma G; Gensler GR; Manukyan Z; Matthews AG; Seifu Y
    Ther Innov Regul Sci; 2016 Mar; 50(2):144-154. PubMed ID: 30227005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review.
    Cragg WJ; Hurley C; Yorke-Edwards V; Stenning SP
    Clin Trials; 2021 Apr; 18(2):245-259. PubMed ID: 33611927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Appraisal of the Carlisle-Stouffer-Fisher Method for Assessing Study Data Integrity and Fraud.
    Mascha EJ; Vetter TR; Pittet JF
    Anesth Analg; 2017 Oct; 125(4):1381-1385. PubMed ID: 28786843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey on statistical methods for health care fraud detection.
    Li J; Huang KY; Jin J; Shi J
    Health Care Manag Sci; 2008 Sep; 11(3):275-87. PubMed ID: 18826005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting medical prescriptions suspected of fraud using an unsupervised data mining algorithm.
    Haddad Soleymani M; Yaseri M; Farzadfar F; Mohammadpour A; Sharifi F; Kabir MJ
    Daru; 2018 Dec; 26(2):209-214. PubMed ID: 30460618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of data audits in detecting scientific misconduct. Results of the FDA program.
    Shapiro MF; Charrow RP
    JAMA; 1989 May; 261(17):2505-11. PubMed ID: 2704109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research misconduct and data fraud in clinical trials: prevalence and causal factors.
    George SL
    Int J Clin Oncol; 2016 Feb; 21(1):15-21. PubMed ID: 26289019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinician-trialist rounds: 19. Faux pas or fraud? Identifying centers that have fabricated their data in your multi-center trial.
    Pogue J; Sackett DL
    Clin Trials; 2014 Feb; 11(1):128-30. PubMed ID: 24096634
    [No Abstract]   [Full Text] [Related]  

  • 19. Scientific Misconduct (Fraud) in Medical Writing.
    Mavrogenis AF; Panagopoulos GN; Megaloikonomos PD; Panagopoulos VN; Mauffrey C; Quaile A; Scarlat MM
    Orthopedics; 2018 Mar; 41(2):e176-e183. PubMed ID: 29377051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data mining application to healthcare fraud detection: a two-step unsupervised clustering method for outlier detection with administrative databases.
    Massi MC; Ieva F; Lettieri E
    BMC Med Inform Decis Mak; 2020 Jul; 20(1):160. PubMed ID: 32664923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.